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ABSTRACT 
Human apul'inic/apyrimidinic endonuclease l/redox effector factor-1 (APEl/Ref·l) is a perfect paradigm of 
the functional complexity of a biological macromolecule. First, it plays a crucial role, by both redox-depen-
dent and -independent mechanisms, as a transcriptional coactivator for different trnnscription factors, either 
ubiquitous (i.e., AP-1, Egr-1, NF-KB, p53, HIF) or tissue-specific (i.e., PEBP-2, Pax-Sand -8, TTF-1), in con-
trolling different cellular processes such as apoptosis, proliferation, and differentiation. Second, it acts, as an 
apurinidapyrimidinic endonuclease, during the second step of the DNA base excision repair pathway, which 
is responsible for the repair of cellular alkylation and oxidative DNA damages. Thil'd, it controls the intracel-
lular reactive oxygen species production by negatively regulating the activity of the Ras-related GTPase Rael. 
Despite these known functions of APEl/Ref-1, information is still scanty about the molecular mechanisms re-
sponsible for the coordinated control of its several activities. Some evidence suggests that the expression and 
subcellular localization of APEl/Ref-1 are finely tuned. APEl/Ref-1 is a ubiquitous protein, but its expression 
pattern differs according to the different cell types. APEl/Ref-1 subcellular localization is mainly nuclear, but 
cytop1asmic staining has also been reported, the latter being associated with mitochondria and/or presence 
within the endoplasmic reticulum. It is not by chance that both expression and sub cellular localization a1·e al-
tered in several metabolic and proliferative disorde1·s, such as in tumors and aging. Moreover, a fundamental 
role played by different posttranslational modifications in modulating APEl/Ref·l functional activity is be-
coming eYident. In the present review, we tded to put togethe1· a growing body of information concerning 
APEl/Ref-l's different functions, shedding new light on present and future directions to understand fully this 
unique molecule. Antioxid. Redox Signal. 7, 367-384. 
INTRODUCTION 
General considerations onAPEl/Ref-1 
biological and molecular functions 
A PEIIREF-1 is a perfect example of the functional com-plexity of a biological macromolecule. Its acronym re-
flects its at least dual nature: human apurinic/apyrimidinic 
(AP) endonuclease, or APEl (also HAP! or APEX), is a 
major constituent of the base excision repair (BER) pathway 
of DNA lesions. Ref-1, the acronym for redox effector factor-
1, refers to its redox abilities on different redox-regulated 
transcription factors (TFs). Interestingly, these two activities 
are split into two functionally independent domains of the 
protein itself: the N-terminus is principally devoted to the 
redox activity, whereas the C-terminus exerts enzymatic ac-
tivity on the abasic sites of DNA (135). Different from the N-
terminus, which is completely u11conserved, the C-terminus is 
highly conserved from plant to man. 
Both of these two activities seem to be fundamental in the 
control of the apoptotic process, as demonstrated by several 
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works (14, 96, 126). APEl/Ref-1 expression is always in-
versely correlated with the onset of apoptosis, suggesting a 
role as an antiapoptotic molecule. 
DNA-repair activity of APEJ/Ref-1 
APEl/Ref- 1 is an essential protein (136) that contributes, 
through its participation in the BER pathways, to the regener-
ation of DNA damaged by products of cell metabolism and by 
environmental hazards. The two best characterized functions 
of APEl/Ref-1 in these pathways are production of a DNA 
primer for repair synthesis and coordination of the repair ac-
tivities ofotherBERproteins (21, 28, 47, 63, 104, 129). 
BER repairs DNA damage with a set of enzyme activities 
that sequentially remove the damaged base (glycosylases), in-
cise the phosphodiester backbone 5' adjacent to the abasic 
site (APEl/Ref-1), excise the abasic residue [APEI/Ref-1, 13 
polymerase, or flap endonuclease 1 (FEN!)], polymerize the 
replacement nucleotide(s) [13 polymerase, x-ray cross-species 
complementing 1 (XRCCl), or M-:polymerases with prolifer-
ating cell nuclear antigen (PCNA)J, and ligate the final se-
quence (DNA ligases I and III, XRCC!) (Fig. 1). 
BER repair synthesis requires a DNA primer with a 3' hy-
droxyl end. APEl/Ref-1 generates this end in three ways. It 
binds specifically (102) and processively (13) to abasic sites, 
generated spontaneously or by glycosylases, and cuts the 5' 
phosphodiester bond with its endonuclease activity to pro-
duce the primer. This endonuclease activity depends on the 
redox state of APEl/Ref-1, controlled in part by amino acid 
C310 (70). APE 1/Ref· l removes with its 3 '-5' exonuclease 
activity a 3'-phospho-a,~-unsaturated aldehyde, formed by 
complex glycosylases [such as the oxidative damage-repair-
ing glycosylases 8-oxoguanine DNA glcosy!ase (Oggl) and 
Nth] and by radiation. This activity may also contribute to the 
fidelity of repair synthesis by removing mispaired nu-
cleotides (132). And, although Jess efficiently than PNK, 
APEl/Ref-1 removes with its 3' phosphatase activity a 3' 
terminal phosphate, produced by glycosylases NEILl and 
NEIL2 and by radiation (63). The repair function of APEl/ 
Ref-1 requires 10 evolutionarily conserved amino acids, D70, 
D90, E96, Y171, D210, N212, D219, D283, D308, and H309 
(35). 
Coordination of these steps within the BER pathway (106) 
and with other DNA repair pathways is thought to be impor-
tant for preventing the accumulation of toxic repair inter-
mediates (105, 131) (each a type of DNA damage) and for 
increasing the overall efficiency of the pathways. Abasic 
sites produced spontaneously or by glycosylases can inhibit 
DNA and RNA polymerases, facilitate mutation, and promote 
single-strand breaks (129, 145). Single-strand breaks pro-
duced by complex glycosylases and by APE!/Ref-1 can in-
hibit polymerases, promote recombination, and become dou-
ble-strand breaks during replication, which in turn can lead to 
chromosome rearrangements and cell death (11). Evidence 
from reconstituted systems and from cell extracts suggests 
that APE 1/Ref-1 contributes to coordination by interacting 
directly or indirectly with other BER enzymes and with other 
repair pathways. The molecular basis of the specificity and of 
the stimulatory mechanisms and the biological significance 
of these interactions remain to be determined. 
TELLETAL. 
The glycosylase MYH (MutY DNA glycosylase homo-
logue) removes adenine and 2-hydroxyadenine mismatched 
with guanine or 7,8-dihydro-8-oxodeoxyguanine (89, 90). 
APEl/Ref-1 increases MYH activity 10-fold in a reconstituted 
system by associating directly with MYH to promote the for-
mation of efficient MYH·DNA complexes by decreasing the 
MYH·DNA substrate dissociation constant (142). Immuno-
precipitation and affinity chromatography show that this as-
sociation requires MYH amino acids 295-317 containing the 
conserved motif SIPG:XZDV/I, where X and Z are any amino 
acids (89). APEl/Ref-1 may also bind directly to methyl-
purine glycosylase, as suggested by in vitro binding studies 
and by far western analysis of a nuclear -30-kDa protein with 
APE!/Ref-1 in CHO cell extracts (35), although yeast two-
hybrid analysis failed to detect this interaction (5). 
Other glycosylases appear to interact with APEl/Ref-1 in-
directly, through competition for DNA binding sites. Glyco-
sylases Ogg! (54), Nth! (74), uracil DNA glycosylase {88), 
and thymine DNA glycosylase (128) display product inhibi-
tion, binding tightly to their processed DNA product. This 
binding may help recruit APEl/Ref-1 to the damaged site and 
protect the AP sites or single-strand breaks until APEl/Ref-1 
continues the repair process. APEl/Ref-1 alleviates this inhi-
bition by displacing the glycosy!ases through its stronger as-
sociation with the DNA. 
Yeast two-hybrid and gel supershift analyses suggest that a 
direct interaction between DNA-bound APE 1/Ref-1 and DNA 
polymerase 13 (5) recruits polymerase 13 to the damaged site, 
stimulating fivefold the rate of removal of the abasic sugar 
(5' dRp) by the lyase activity of polymerase 13. This stimula-
tion and consequent repair synthesis in turn increase APEl/ 
Ref-I endonuclease activity, by removing through repair syn-
thesis the 3' terminus that effects product inhibition of APE!/ 
Ref-I (77). 
In addition to its role in single-strand break repair, XRCCl 
may act as a scaffold to physically organize the BER process. 
XRCCl binds directly to APEl/Ref-1 in yeast two-hybrid, far 
western, and affinity chromatography assays (122). This in-
teraction requires the N-terminus of APEl/Ref-1, stimulates 
the rate of APEl/Ref-1 endonuclease activity fivefold, and 
stimulates the 3' phosphodiesterase activity. Extracts pre-
pared from CHO cells defective in XRCCl activity show di-
minished APEl/Ref-1 endonuclease activity that is rescued 
by addition of XRCCl. Stimulation of this endonuclease ac-
tivity may also decrease the lyase activity of Ogg 1 to increase 
the efficiency of repair (75). 
Coprecipitation and affinity chromatography show that 
PCNA, the sliding clamp processivity factor of DNA poly-
merases l'i and E, and FENl, the flap endonuclease oflong-patch 
BER, bind directly to APEl/Ref-1 (22). APEl/Ref-1 stimulates 
flap excision twofold in a reconstituted system, suggesting the 
APEl/Ref-1 interaction with FENl may be functional. Tom et 
al. (118) have suggested that the ability ofAPEl/Ref-1 to orga-
nize BER proteins in the presence and absence of PCNA may 
contribute to the differential regulation of BER and DNA repli-
cation during oxidative stress mediated by p21. 
p53 binds directly to APEl/Ref-1 and stimulates BER, al· 
though the relationship of the binding and stimulation is un-
known and p53 is not required for BER (105). Far western 
analysis of purified proteins and immunoprecipitation west-
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FIG. 1. Representations of APEl!Ref-1 structnre and functions. (A) Schematic structure of APEl/Ref-1 with critical 
residues. NLS, nuclear localization signal. Cylinders represent a-helical regions, and arrows represent (3,-strands, as deduced by 
Gorman et al. (44). (B) APEl/Ref.1 functions in BER. MPG, methylpurine DNA glycosylase; RFC, replication factor C. (C) 
Theoretical molecular model of the redox function of APEl/Ref-1 as a transcriptional coactivator. DBD, DNA binding domain. 
ern analysis of H24-14 cell extracts show that the tumor su-
pressor p53 binds directly toAPEl/Ref-1 (41). p53 also stim-
ulates BER in nuclear extracts and in reconstituted systems, 
dependent on its N-terminal transactivating region (146). 
Equal APEI/Ref-1-specific activities in extracts prepared 
from isogenic cell lines with wild-type and suppressed p53 
suggest th at the stimulation is not due to interaction between 
p53 andAPEl/Ref-1 (101). 
APEl/Ref-1 protein interactions may also influence DNA 
repair pathways other than BER. Affinity chromatography 
and gel mobility shift assays show that the single-strand 
break repair proteins Ku 70/80 bind APEl/Ref-1 (16). 
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FIG. 2. Schematic 1·epresentation of some of the stimuli known to activateAPEl/Ref-1 expression and/or function. 
Whether this interaction affects either BER or single-strand 
break repair is unknown. 
Red ox regulation of TFs activities 
Redox regulation of cellular functions occurs as a conse-
quence of the so-called "redox-cellular status," which is the re-
sult of a balance between the activity of antioxidant enzymatic 
cell systems (such as GSH/GSSG, superoxide dismutase, cata-
lase, peroxidases, glutathione peroxidases, etc.) and the amount 
of reactive oxygen species (ROS) such as superoxide anion 
(02-'), hydrogen peroxide (Hp2), and hydroxyl radical COH). 
These last molecules can be produced in several ways: as by-
products of respiration, thus being associated with cell prolif-
eration rate; by external noxious agents, such as ionizing radia-
tion (127); during pathological states in activated neutrophils 
(80); and as "second messengers" produced by intracellular en-
zymatic systems, such as NADPH oxidase regulated by the 
ubiquitous small GTPase Rael (20, 24, 43). It therefore repre-
sents a useful tuning device for intracellular signal transduc-
tion, as is the case in cascades induced by cytokines, such as 
tumor necrosis factor-a or interleukin (IL)-~ (80). 
This redox regulation ultimately affects gene expression. 
Recently, a great body of experimental evidence suggested 
that these outcomes are achieved through modulation of TFs 
activity, Up to now, several TFs containing specific Cys 
residues have been demonstrated to be the target ofredox reg-
ulation. APE!/Ref-1 has been identified as a protein capable 
of nuclear redox activity, inducing the DNA-binding activity 
of several TFs, such as AP-1 (133), NF-KB (83), Myb (134), 
PEBP-2 (1), HLF (27), NF-Y (81), Egr-1 (60), HIF-la (59), 
ATF/CREB family (134), p53 (41), Pax proteins (12, 1 IO, 
112). It accomplishes this through the control of the redox 
state of Cys residues located in the DNA-binding domains or 
within regulatory regions, such as the transactivation domain 
of the thyroid-specific transcription factor I (i.e., TTF-1) of 
the TFs themselves (115). In order to properly bind specific 
DNA target sequences, these TFs require that critical Cys 
residues are in the reduced state. Therefore, by maintaining 
these cysteines in the reduced state, APE/Ref-1 provides a 
redox-dependent mechanism for regulation of target gene ex-
pression. APE/Ref-1 contains two cysteine residues located 
within the redox-active domain (Cys65 and Cys93), and pre-
vious studies show that Cys65 should be the redox-active site 
of the protein by using recombinant protein (123). In agree-
ment with the molecular model describing redox regulation 
exerted by APEl!Ref-1, Cys65 should interact with the sensi-
tive cysteine residues within the DNA-binding domains of 
TFs. However, Jayaraman et al. (64) suggest that the stimula-
tory role played by APEI/Ref-1 on p53 activity may also 
occur in a redox-independe11t way. This has been recently cor-
roborated by the work of Ordway et al. (85) in which the au-
thors provide first ill vivo evidence that the Cys65 residue of 
APEl!Ref-1 is, unexpectedly, not essential for redox regula-
tion of AP-1 DNA binding. However, these authors did not 
completely exclude a possible presence of compensatory phe-
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nomena. In any case, this evidence challenges previous hy-
potheses about the molecular mechanisms by which APEl/ 
Ref-I exerts its redox-dependent activities of specific TFs. 
According to the proposed redox-regulatory role on cellu-
lar functions played by APEl/Ref-1, both gene expression 
and protein levels are up-regulated by nontoxic levels of a va-
riety of ROS and/or ROS-generating systems (Fig. 2). 
REGULATION OF APEl/Ref-1 
FUNCTIONS: AT THE GENE EXPRESSION 
LEVEL AND POSTTRANSLATIONAL 
(PT) MODIFICATIONS 
Early evidence of APEl/Ref-1 regulatiot1 came from ex-
pression studies. It was immediately clear that APEI/Ref-1 
expression was principally controlled at the transcriptional 
level {Table 1). Several studies, both in vivo and in vitro, 
clearly demonstrated that different oxidative agents effi-
ciently and quickly (within minutes to hours) promote 
APEl/Ref-1 transient increase at both the mRNA and protein 
levels (Fig. 2). As it is blocked by cyclobeximide, the latter 
process requires de nova protein synthesis (94, 112). Up-reg-
ulation of APEl/Ref-1 protein levels appears to have biologi-
cal relevance. In fact, protein up-regulation is always associ-
ated with an increase in both redox and AP endonuclease 
activity, followed by an increase in cell resistance toward ox-
idative stress and DNA-damaging agents (46, 94). Therefore, 
an important issue was the identification of extracellular sig-
nals able to increase APEl/Ref-1 gene expression. 
As experimental data grew, so did research aimed at identi-
fying biological mod\1lators of APEl/Ref- 1 gene expression, 
such as hormones and cytokines. With respect to these obser-
vations, recent articles by our group (113, 116) together with 
that of Asai et al. {3) depicted a clear view of the thyrotropin 
{TSH)-induced APEl/Ref-1 gene expression in thyroid cells. 
It became immediately clear that functional triggering of 
membrane-bound receptors could be responsible for a posi-
tive regulation of APE l/Ref-1 gene expression itself for other 
cell systems. Such an example is represented by the human 
chorionic gonadotropin that has been previously demon-
strated to induce APEl/Ref-1 mRNA synthesis in murine 
Leydig cells (107). In the case of the immune system, a phys-
iological induction of APEl/Ref-1 gene expression has been 
recently demonstrated for at least two cell types. This is the 
case of human alveolar macrophages stimulated with granu-
locyte-monocyte colony-stimulating factor (31 ), which can 
be released by these cells during fibrotic processes in the 
lung, and of spleen B cells stimulated with CD40 ligand {78). 
In the first case, a functional role in AP-I transcriptional ac-
tivity has been proposed. In the latter case, the CD40 trigger-
ing is functional to the activation of blk promoter operated by 
Pax5a and EBF TFs. A role for IL-2-stimulated APEl/Ref-1 
up-regulation has also been demonstrated in a murine pro-B 
cell line (140). Very recently, a functional role for this process 
has been suggested involving redox regulation oftelomerase 
activity (137). 
Other soluble mediators that have been investigated deal-
ing with APEl/Ref-1 expression are dopamine and glutare-
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doxin {Grx2) in cerebellar granule neurons. Daily et al. (17) 
demonstrated that the endogenous neurotransmitter of the 
nigrostriatal pathway, i.e., the proapoptotic dopamine, exerts 
an inhibitory effect onAPEl/Ref-1 expression that is squelched 
by the antioxidant Grx2, thus leading to NF-KB activation and 
to cell protection from apoptosis. 
APEl/Ref-1 levels seem to act as an intracellular signaling 
device. In fact, its protein levels correlate with the propensity 
of the cell to undergo apoptosis or proliferation. In practice, 
modulation of APEl/Ref-1 protein expression has been de-
scribed for almost every cell type depending on the particular 
cellular redox status induced by exposure to an oxidative en-
vironment (Table 1). Moreover, physiological stimuli, such as 
those of cytokines, are able to promote APE 1/Ref-1 up-regu-
lation. Indeed, cell systems must be able to discriminate these 
different stimuli if APEl/Ref-1 behaves as a signaling mole-
cule. 
At present, it is not known what the primum mavens re-
sponsible for APEl/Ref-1 gene expression upon oxidative 
stress is or the signaling pathways leading to its activation. A 
major role seems to be represented by cyclic AMP as a com-
mon second messenger in the case of both TSH and H20 2 
stimulations (3, 116). However, from the comparative study 
of cytokine- and ROS-induced APEl/Ref-1 up-regulation, 
some conclusions could be drawn about the molecular 
switches responsible for its modulated expression. Moreover, 
as APEl/Ref-1 expression represents a molecular marker of 
oxidative stress, it would be important to understand the dis-
section of signaling pathways responsible for its role in regu-
lating the mechanisms of ROS-induced cell responses. 
The human APEl/REF-1 gene is located on chromosome 
14q 11.2-12 and span 2.6 kb, and consists of four intrans and 
five exons, the first of which is non coding. Its cis-regulatory 
regions are composed of a proximal basal promoter of -300 
bp containing a CpG island (Fig. 3A). Within this area, sev-
eral putative binding sites for redox-regulated (such as AP-1, 
Sp-1, andATF) or cyclic AMP-regulated (such as CREB) tran-
scriptional factors are present. At the distal promoter level, at 
least three negative calcium-responsi\'e regulatory elements 
(nCAREs) were found: nCaRE-A, nCaRE-Bl, and nCaREB2 
(62). By binding to one of these regulatory elements (nCaRE-
B2), APEl/Ref-1 is able to repress its own expression, thus 
providing a means to control its intracellular levels (62). 
Therefore, APEl/Ref-1 can also exert transcriptional control 
by binding to specific DNA sequences in cooperation with 
hnRNP-L, a member of the heterogeneous ribonucleoproteins 
(73). This has also been confirmed by findings demonstrating 
the ability of APEl/Ref-1 to repress the parathyroid hormone 
(PTII) gene expression (84). In fact, PTH promoter is charac-
terized by the presence of a nCaRE binding motif that is spe-
cifically recognized by APEl/Ref- 1. 
Despite the fact that the APEl/Ref-1 gene was cloned sev-
eral years ago (50) and its promoter characterized in detail 
(52), very few articles have addressed the molecular mecha-
nisms responsible for its inducible regulation. Up to 11ow, the 
unique ascertained contributors to APEl/Ref-1 transcrip-
1 tional activation are that of Jun/ATF2 in an inducible way in 
response to oxidative stress ( 45) and that of Sp-1 required for 
both the basal (region -65 to -17 from the transcription start 
site) and the coordinate (region +99 to +183) expression of 
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TABLE 1. SUMMARY OF STUDIES DES!Gl\'ED TO INDUCE APEIREF-1 AT THE MRNA AND/OR THE PROTEIN LEVELS 
Treatment or 
pathological Gene Subcel/ular 
Tisrne!cells condition expression compartment Reference Proposed biological ro{e 
HT-29 Hypoxia j 144 Involvement in detoxification of 
xenobiotics 
He La UV and hypoxia j 124 Protection against hypoxic stress 
Rat dentate gyrus Ischernia j N 42 Neuronal protection against 
(granular cells) oxidative stress 
Rat hippocampus Ischemia t N 42 Neuronal protection against 
(CAl neurons) oxidative stress 
Hypoxic- J, 125 Development of apoptosis 
ischemic insult 
CHO ROS t 46 Clastogenic adaptive response to 
oxidative stress 
HeLa S3 and WI38 ROS t 94 Adaptive response to ROS causing 
enhanced repair of cytotoxic 
DNA lesions 
Raji (B lymphocytes) ROS t N 112 Redox regulation ofTFs activity 
t M 36 DNA repair 
Rat hippocarnpus Ischernia J, 26 Development ofapoptosis 
Rat mesothelial cells Asbestos t 39 DNA repair 
FRTL-5 (rat thyroid cells) TSH,ROS, t N 3, 113, Redox regulation ofTFs activity 
elevation in 116 
intracellular 
Ca2+ 
Rat SON and PVN cells Hypertonic 95 DNA repair 
Rat SCNcells Light 95 DNA repair 
Porcine epidermis Wound healing t 51 DNA repair 
MA-IO hCG i 107 Redox regulation ofTFs activity 
Liver Ischemia/ t 87 Redox regulation ofTFs activity, 
reperfusion Control of intracellular ROS 
production 
CPAEC and HUVEC Hypoxia J, 49 Redox regulation ofTFs activity 
RBL-2H3 mast cells ROS t N 37 Redox regulation ofTFs activity 
Spleen B cells CD40 triggering t N 78 Redox regulation ofTFs activity 
HT29 colon Dithiolethione i 143 Redox regulation ofTFs activity 
adenocarcinoma cells oltipraz 
Alzheimer's disease Chronic ROS j 19 DNA repair 
Rat kidney Aging i N 15 Redox regulation ofTFs activity 
Human choriodecidual Elevation in t N 38 Transcriptional repression 
cells intracellular 
Ca2+ 
Rat liver treated with ROS i M 56 DNA repair 
WYI4,643 
J, Rabbit spinal cord Ischemia 99 DNA repair, development of 
Human atherosclerotic ROS t 
apoptosis 
76 DNA repair 
plaques 
i Human fibroblasts Arsenic 58 Redox regulation ofTFs activity 
HUVEC Hypoxia/ i N 2 Redox regulation ofTFs activity 
reoxygenation 
i Human macrophages Asbestos N 32 Redox regulation ofTFs activity 
Human alveolar GM-CSF i 31 Redox regulation ofTFs activity 
macrophages 
t K562 human PMA, 57 Redox regulation ofTFs activity, 
rnyeloid cell line hypochlorite, DNA repair 
MMS 
BA/F3 murine pro-B IL-2 t 140 Redox regulation ofTFs activity 
cell line 137 Stimulation oftelomerase 
activity 
(continued) 
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TABLE L (CONIINUED) 
Treatment or 
pathological Gene Subcellular 
Tissue/cells condition expression compartment Reference Proposed biological role 
Murine cerebellar Dopamine J, 17 Redox regulation ofTFs activity 
granule neurons 
t Murine cerebellar GRx2 N/C 18 Redox regulation ofTFs activity, 
granule neurons 
t 
protection from apoptosis 
Astrocyte primary cultures Pb N 100 Redox regulation ofTFs activity 
CHO ROS t 45 Redox regulation ofTFs activity 
Rat tamoxifen-induced Tamoxifen j 69 Redox regulation ofTFs activity, 
hepatocarcinogenesis DNA repair 
Rat duodenal mucosa Cysteamine- t N 71 Redox regulation ofTFs activity 
induced 
duodenal 
ulceration 
H\nnan placenta Preeclampsia t 108 DNA repair 
C, cytoplasm; CPAEC, calf pulmonary artery endothelial cells; GM-CSF, granulocyte-monocyte colony-stimulating factor; 
hCG, human chorionic gonadotropin; HUVEC, human umbilical vein endothelial cells; M, mitochondria; MMS, methyl 
methanesulfonate; N, nucleus; PMA, phorbol 12-myristate 13-acetate; PVN, paraventricular nuclei; SCN, suprachiasmatic nuclei; 
SON, supraoptic nuclei. 
APEl/Ref-1 during cell cycle (40). These last results were 
obtained in the case of the mouse promoter. However, as a 
conserved Sp-1 binding site located downstream from the +1 
transcription start site is present in the human promoter (re-
gion about +76 to +85), a similar behavior could be expected. 
Very recently, an important role in the control of APEl/Ref-1 
gene expression has also been suggested for the signal trans-
ducer and activator of transcription-3 (Stat3) TF in liver ( 48), 
suggesting a new mechanism of protection against Fas-medi· 
ated liver injury. These findings confirm that much work re-
mains to be done in order to elucidate, in detail, the molecular 
mechanisms of controlling APEi/Ref-i gene expression. 
Due to the fact that recombinant APEl/Ref-1 expressed in 
E. coli fully retains functional redox and endonuclease activ-
ity, it was erroneously thought for several years that APEI/ 
Ref-1 was not subjected to PT modifications. The only func-
tional exception to perfectly similar behavior between en-
dogenous and recombinant APEI/Ref-1 was represented by a 
differential binding activity toward the nCaRE sites. In fact, 
recombinant APEl/Ref-1 alone was not able to bind to both 
nCaRE-A and nCaRE-B in the PTH gene promoter, indicat· 
ing a requirement for additional factors in the complex ( 16, 
73). These observations led to the identification of Ku70 
(K.u86) and hnRNP-L involvement in the complex formation 
with nCaRE-A and nCaRE-B, respectively. Moreover, APEl/ 
Ref-I is an abundant protein in a eukaryotic cell. We have es-
timated that~ 10-3 0,000 copies of the protein are present in a 
thyroid cell. Therefore, it is possible that many proteins for 
many different functions have to be "finely tuned" in order to 
coordinate specific biological activities. The best choice for a 
biological system to "recycle" the same protein for different 
biological activities is by means of PT modifications. First, in 
silico studies soon discovered that several different phospho-
rylation sites were scattered throughout the molecule. These 
potential phosphorylation sites included consensus sequences 
for casein kinase I and II (CKl and CKII), for protein kinase 
C (PKC), and for glycogen synthase kinase 3 (GSK3) {Fig. 
3B) (34, 139). These two pioneering studies were, however, in 
disagreement regarding the potential phosphorylation sites 
determined and the functional consequences ofi11 vitro phos-
phorylation. 
These first studies were performed in vitro by using the re-
combinant APEl/Ref-1 protein expressed in E. coli. The first 
ill vivo study was that of Hsieh et al. (57), which demon-
strated for the first time the occurrence of a PKC-mediated 
phosphorylation on APEl/Ref-1 protein. Unfortunately, these 
a11thors did not determine the location of the specific phos-
phorylation site. The PKC-mediated phosphorylation was 
able to promote the redox activity of APE I /Ref- I on AP-1 TF 
in response to phorbol 12-myristate 13-acetate treatment or to 
the oxidizing agent hypochlorite followed by methyl methane 
sulfonate treatment. However, this study did not address the 
question of whether endonuclease activity of APEl/Ref-1 is 
affected by PKC phosphorylation. 
Another PT modification that was initially suspected and 
finally demonstrated i11 vitl'O was redox modification. Initial 
evidence came from studies of association with the dithiol-
reducing enzyme thioredoxin (TRX) (55, 93, 121). Although 
the specific residues of APEI/Ref-1 involved in interaction 
with TRX are not known, Cys35 and Cys32 in the catalytic 
center of TRX have been demonstrated to be involved. As it 
was previously demonstrated that Cys65 and Cys93 of APEl/ 
Ref-I are redox-sensitive (123, 124, 135), it could be specu-
lated that target residues of TRX interaction may include 
these two cysteine residues. This TRX-mediated redox regu-
lation of APEl/Ref-1 is required for p53 and AP- I functional 
activation (55, 121). Very recently, Kelley and Parsons (70) 
demonstrated that the repair activity is also redox-regulated 
with the specific involvement ofC310 residue located imme-
diately adjacent to the crucial histidine residue at position 
309 within the DNA repair active site. Interestingly, oxidation 
occurring at other Cys residues located in the redox domain 
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does not affect the repair activity, confirming the functional 
independence of the two domains of APEl/Ref-1. The struc-
tural and functional modularity of APEl/Ref-1, together with 
this new evidence of different sensitivity toward different 
specific PT modifications, could explain the fine-tuning re-
quired for proper function of the protein. 
PT regulation of APEI/Ref-1 protein is responsible for en-
hanced cell death mediated by granzyme A (GzmA) (30) in 
K562 cells. APEl/Ref-1 is associated with the endoplasmic 
reticulum {ER) in a macromolecular complex of 270-420 
kDa containing evolutionarily conserved proteins called SET, 
pp32, and HMG2. GzmA cleaves APEl/Ref-1 after Lys31 
and destroys its known DNA repair functions, forcing the cell 
to undergo apoptosis. These recently published data suggest 
that a complex array of interrelationships may control APEl/ 
Ref-1 function. 
Lastly, acetylation occurring on APEl/Ref-1 protein has 
very recently been found by Bhakat et al. (6). The transcrip-
tional coactivator p300, which is activated by Ca2+, is able to 
specifically acetylate APEI/Ref-1 both i11 vitro and in vivo. 
Acetylation at Lys6 or Lys7 enhances DNA binding of 
APEl/Ref-1 to nCaRE sequences, thus unraveling a means to 
down-regulate the PTH promoter by APE 1/Ref-1 itself. These 
authors showed that APElffi.ef-1 protein is heterogeneously 
PT modified in HeLa cells used in this study. Interestingly, 
and more generally, this heterogeneity is not restricted to the 
cell line used in this work because our studies, performed on 
rat FRTL-5 cells and human HOBIT osteoblastic cells by 
using two-dimensional gel electrophoresis {2-DE) analysis 
coupled to western blot identification, confirmed that APEl/ 
Ref-1 is heterogeneously present in cell nuclear extracts at 
basal conditions (see Fig. 3C). 
Together, these recent observations have raised the possi-
bility that subtle PT modifications provide a means for chan-
neling the multifunctional APEl/Ref-1 to different activities 
and interactions and thus could act as a regulatory switch in 
performing different functions. 
REGULATION OF APEl/Ref-1 
FUNCTIONS: AT THE SUB CELLULAR 
LOCALIZATION LEVEL 
Most reports have APEl/Ref-1 localized to the nucleus, 
but a growing body of evidence has shown that in some cell 
types, particularly those with high metabolic or proliferative 
rates, such as spermatocytes, thyrocytes, lymphocytes, hepa-
tocytes, and hippocampal cells, APEl/Ref-1 can be cytoplas-
mic (25, 65, 67, 95, 112, 113, 130). Recent advances pro-
vided at least two functional explanations for the cytoplasmic 
expression of APEl/Ref-1. Previous evidence comes from 
our work on mitochondrial localization of APEl/Ref-1 {114), 
confirming previous findings by Fung et al. (39) and Tomkin-
son et al. (119). Due to occurrence of oxidative phosphoryla-
tion, mitochondria produce a large amount of ROS. Mita· 
chondrial DNA (mtDNA), being located in the mitochondrial 
matrix, is extremely susceptible to oxidative damage, which 
represents a major mutational drive for mtDNA itself. The ex-
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istence of DNA repair devices in mitochondria is still up for 
debate (8). However, the presence of the major abasic en-
donuclease repair enzyme APEl/Ref-1 in this subcellular 
compartment would account for the existence of a BER 
mechanism in mitochondria. The latter functional explanation 
of APEi/Ref-I cytoplasmic location is related to its associa-
tion with ER membranes. By using electron microscopy im· 
munocytochemistry, we evidenced this association in FRTL-5 
thyroid cells (114). However, more functional information 
about ER localization of APEl/Ref-1 protein came from re-
cent work by Fan et al. (29, 30). APEl/Ref-1 associates with 
the tumor suppressor protein pp32 and with the nucleosome 
assembly protein SET in the so-called SET complex in K562 
and HeLa cells. Within this context, APEl/Ref-1 together 
with the HMG2 architectural TF was demonstrated to be a 
physiologically relevant GzmA substrate in targeted cells. In 
so doing, GzmA may block cellular repair and force cells into 
apoptosis. 
Moreover, cytoplasmic localization may be required in 
order to maintain newly synthesized TF in a reduced state 
while they are being translocated to the nucleus. In this re-
spect, Duguid et al. (25) demonstrated an association of 
APEl/Ref-1 with ribosomes in the cytoplasm ofhypoglossal 
neurons. 
Another level of complexity in understanding the regula-
tion/meaning of APEI/Ref-1 biological functions is repre-
sented by the widespread observation that the subcellular dis-
tribution of this protein is somewhat heterogeneous within 
cell subpopulations. This is the case of cerebellar granule 
cells. Their APEI/Ref-1 staining is mostly cytoplasmic, 
whereas adjacent cells show intense nuclear staining (67). 
The recent observation that APEl/Ref-1 is subjected to a cell 
cycle-dependent expression (40) could explain this. These 
data, paired with the demonstration of cell cycle-dependent 
hMYH glycosylase expression (9), suggest that coordinated 
expression of key DNA repair genes with the cell cycle is a 
general phenomenon. Moreover, as APEl/Ref-1 plays an im-
portant role in contributing to p53-mediated cell-cycle arrest 
( 41) by regulating p53 TF activity through both redox-depen-
dent and -independent mechanisms (64), and it is down-regu-
lated during apoptosis in myeloid leukemia cells (96), then it 
is possible that the role of cell cycle-responsive APEl/Ref-1 
expression relates to one of these other functions rather than 
to DNA repair. 
Finally, in many cell types, APEl/Ref-1 displays both 1rn-
clear and cytoplasmic localization. These cell types include 
normal thyroid cells stimulated by TSH, transformed thyroid 
cells {113), mucosa! and parietal cells of the stomach, cere-
bellar Purkinje cells, adrenal cortical cells, and some cervical 
cells (67, 95). 
Therefore, to sum up, APEl/Ref-1 subcellular localization 
is quite varied. Some cell types exhibit only nuclear localiza-
tion, others display only cytoplasmic, and some others show 
both nuclear and cytoplasmic localization. Such a complex 
staining pattern suggests that localization is not random but, 
on the contrary, is governed by a strictly regulated process. 
The understanding of the biological relevance of subcellular 
compartmentalization is now at its very begiru1ing, but recent 
articles suggest that this field shows much promise. 
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APEl/Ref-1 FUNCTIONS, SUBCELLULAR 
MOVEMENT, AND TRAFFICKING 
Generally, stimuli that promote APEl/Ref-1 expression 
are also able to promote its intracellular movement. The 
amount of evidence reporting APEl/Ref-1 subcellular relo-
calization upon a stimulus has grown exponentially in the last 
few years and is shown in Table 2. Most of the observed sub-
cellular relocalizations are cytoplasm-to-nucleus APEl/Ref-1 
translocations. Different cellular conditions are able to per-
turb the APEl/Ref-1 intracellular localization. Five cate-
gories of cellular stimuli can be identified: (a) prooxidant 
injuries, such as neuronal ischemia ( 42), hypoxia/reoxygena-
tion in endothelial cells (2), cysteamine-induced duodenal ul-
ceration (71), and aging (15); (b) heavy metals exposure, 
such as macrophages exposed to asbestos (32), and primary 
astrocyte cultures exposed to Pb (100); (c) direct ROS expo-
sure, as in the case of B-lymphocytes (36, 112) or mast cells 
(37); (d) hormone or cytokine stimulation as in the case of 
TSH-stimulated thyroid cells (113), or CD40-triggering in 
splenic B-cells (78) and FcERI signaling in mast cells (37); 
and (e) increase in intracellular Ca2+ concentration in both 
choriodecidual cells (38) and thyroid cells (116). 
The question of how eukaryotic cells regulate the localiza-
tion of APEl/Ref-1 with regard to the redox condition re-
mains open. In many cases, it has been demonstrated that PT 
modifications, i.e., phosphorylation at the level of nuclear lo-
calization signal (NLS), are responsible for the regulation of 
the protein levels present in the nuclear compartment. Com-
putational analysis reveals that APEl/Ref-1 possesses a sin-
gle consensus sequence for CK.II at position 18-21, a region 
containing a NLS (TEPE). In particular, treatment ofFRTL-5 
thyroid cells with quercetin, a highly specific CK.II inhibitor, 
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is able to induce translocation of APE 1/Ref-1 into the nucleus 
(unpublished observations), suggesting that the nuclear form 
of APE! could be hypophosphorylated. Therefore, it is tempt-
ing to speculate that a dephosphorylating event is required for 
the nuclear localization of APEl/Ref-1 in thyroid cells, as in 
the case of the NF-AT TF (103). 
As APEl/Ref-1 directly and physically interacts with 
redox-regulated TFs, this raises the possibility that nuclear 
relocalization could be, at least in part, due to a co-trans-
portation mechanism by those TFs, such as NF-KB, that are 
specifically relocalized to the nucleus due to a stimulus and 
have been demonstrated to functionally interact with APEl/ 
Ref-1 itself. This would not represent an isolated case of such 
a mechanism, being corroborated by recent reports for a role 
in cotransport of ~-catenin by the LEF-1 TF (61). 
Another interesting evidence is the case of the observed re-
localization of APEI/Ref-1 into mitochondria of the B-lym-
phocyte Raji cell line following Hp2 activation (36). This re-
localization is not associated with cytochrome c loss or with 
apoptosis induction, thus indicating that the APEl/Ref-1 
translocation into mitochondria upon oxidative stress might 
exert a protective function toward mtDNA damages produced 
by both exogenous and endogenous ROS. Due to the rela-
tively high molecular weight of APEl/Ref-1, which is not 
fully compatible with a passive mechanism of translocation 
through the outer membrane of mitochondria, the presence of 
a specific regulatory transport mechanism could be hypothe-
sized. Although a large majority of proteins synthesized in 
the cytoplasm localize into mitochondria by means of an N-
terminal presequence, or mitochondrial targeting sequence 
(MTS), a significant fraction of mitochondrial proteins lack 
this recognition signal. Little is known about other mitochon-
drial targeting signals, but there could be targeting signals 
within the molecule itself. This is the situation, for instance, 
TABLE 2. SUM}.fARY OF STUDIES DESIGNED TO INDUCEAPEl/REF· 1 SUBCELLULAR RELOCALIZAT!ON 
Treatment or 
pathological Subcellular 
Tis sr1e/cell s condition compartment Translocation Reference Proposed biological role 
Rat hippocampus Ischemia N + 42 Neuronal protection against 
(CAl neurons) oxidative stress 
Raji (B lymphocytes) ROS N + 112 Redox regulation ofTFs activity 
M + 36 DNA repair 
FRTL-5 (rat TSH, ROS, elevation N + 113, 116 Redox regulation ofTFs activity 
thyroid cells) in intracellular Ca2+ 
Spleen B cells CD40 triggering N + 78 Redox regulation ofTFs activity 
Rat kidney Aging N + 15 Redox regulation ofTFs activity 
Human choriodecidual Elevation in N + 38 Transcriptional repression 
cells intracellular Ca2+ 
HUVEC Hypoxia/reoxygenation N + 2 Redox regulation ofTFs activity 
Human macrophages Asbestos N + 32 Redox regulation ofTFs activity 
Astrocyte primary Pb N + 100 Redox regulation ofTFs activity 
cultures 
Rat duodenal mucosa Cysteamine-induced N + 71 Redox regulation ofTFs activity 
duodenal ulceration 
RBL-2H3 mast cells ROS and N + 37 Redox regulation ofTFs activity 
FcERI-signalling 
HUVEC, human umbilical vein endothelial cells; M, mitochondria; N, nucleus. 
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in the heme lyases that have, in the third qnarter of the mole-
cule, a hydrophilic stretch of residues that represent a 
topogenic signal for protein sorting into the intermembrane 
space (23). APEI/Ref-1 does not present a classical mito-
chondrial N-terminal presequence while presenting, in the 
same region, a typical NLS in the first 20 residues. Therefore, 
it could be speculated that the mitochondrial localization sig-
nal may reside in another region of the molecule instead of 
the N-terminus. Obviously, identification of such a signal 
would represent an important discovery that would elucidate 
some of the functional roles ofAPEl/Ref-1. Recently, Tsuchi-
moto et al. ( 120) demonstrated the presence of MTS in APE2, 
which is a classical mammalian AP endonuclease enzyme be-
longing to the same functional category as APE!/ Ref-1. As 
opposed to APEl/Ref-1 at1d other members of this functional 
category, the presence of a 15-stretch amino acid N-terminal 
sequence resembling a canonical MTS is responsible for the 
localization of the protein within mitochondria. As in the case 
of APEl/Ref-1, APE2 is also localized within the nucleus of 
HeLa cells. Despite this evidence and opposed to APEl/Ref-1, 
APE2 does not possess a classical NLS that can justify nu-
clear localization. However, this subcellular localization seems 
to be ascribable to the presence of a PCNA binding motif in 
the C-terminus of the protein through which it physically in-
teracts with PCNA itself. 
A recent role that has been proposed for the cytoplasmic 
APEI/Ref-1 came from studies on endothelial and liver ox-
idative stress by hypoxia/reoxygenation-induced oxidative 
stress (2, 87). From these studies, a new role for APEI/Ref-1 
in protecting cells from apoptosis induced by oxidative stress 
was suggested. In fact, APEl/Ref-1 is able to inhibit oxida-
tive stress by inhibiting ROS generation by the cytoplasmic 
small GTPase Rael, therefore accounting for a new and unex-
plored extranuclear role of APEl/Ref-1. 
ALTERED EXPRESSION/DISTRIBUTION 
OF APEl/Ref-1 AND HUMAN PATHOLOGY 
The multifunctional properties of APEl/Ref-1 closely par-
allel the differential expression pattern found in a wide spec-
trum of cells first realized by Kakolyris et al. in 1998 (67). In 
the following years, many articles observed that this hetero-
geneity of expression pattern is also linked to different patho-
logical conditions ranging from metabolic to differentiative 
disorders. Early studies by Kakolyris et al. showed that differ-
ent kinds of human tumors were characterized by alterations 
in subcellular distribution of APEl/Ref-1 with respect to nor-
mal tissue. This is the case, for instance, in colorectal carci-
noma. In normal colorectal mucosa, the predominant staining 
is nuclear in the less differentiated cells of the lower part of 
the crypt, but is cytoplasmic in the more differentiated and 
superficial colonic epithelium. This distribution is com-
pletely disrupted during tumorigenesis because the nuclear-
restricted pattern is lost in both adenoma and carcinoma, 
which display nuclear and cytoplasmic localization with a 
predomination of the latter, in front of a prominent nuclear 
localization in the normal tissue (65). A similar pattern has 
been described for breast cancer. In normal tissue, the 
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APEI/Ref-1 localization is eminently nuclear, whereas in 
carcinomas, nuclear, cytoplasmic, and nuclear/cytoplasmic 
stainings were observed. This peculiar distribution correlates 
well with aggressiveness and prognosis of the tumor: nuclear 
localization was always associated with a better prognostic 
feature being related to better differentiation, low angiogene-
sis, and negative lymph node status. In contrast, both the cy-
toplasmic and the nuclear/cytoplasmic stainings were associ-
ated with poor prognostic factors, such as angiogenesis 
together with node and p53 positivities (66, 92). Interestingly, 
there seems to be no functional relationship between alter-
ations in subcellular distribution of APEI/Ref-1 and the abil-
ity of cancerous tissue to repair abasic sites, suggesting that, 
at least in breast cancer, DNA repair by BER is not affected 
(98). As an aside, Bobola et al. (7) demonstrated that even an 
increase in AP endonucleasic activity occurs in human 
gliomagenesis with a concomitant elevation of APEl/Ref-1 
protein expression level. Similar observations have also been 
made by Robertson et al. (97). In different germ cell tumors, 
such as seminomas, yolk sac tumors, and malignant tera-
tomas, APEl/Ref-1 expression levels and DNA repair ability 
correlated and conferred a proportional level of protection 
from bleomycin treatment. These outcomes suggest that a 
consequence of the increase in AP activity accompanying tu-
morigenesis could be enhanced resistance to radiotherapy and 
chemotherapy. 
A disregulation in nuclear versus cytoplasmic ratio toward 
a more cytoplasmic staining was also observed in thyroid car-
cinomas (113) and epithelial ovarian cancers (79) with re-
spect to normal tissue. 
In other studies, a quantitative evaluation of APEl/Ref-1 
expression was taken into consideration. In cervical ( 13 8), 
non-small cell lung cancer (68, 91), rhabdomyosarcomas 
(ll 7), and squamous cell head-and-neck cancer (72), a strong 
up-regulation at the nuclear level of APEI/Ref-1 was always 
observed. Some studies suggested that APEl/Ref-1 levels 
and/or subcel!ular disregulation may be used as a therapeutic 
index to indicate the sensitivity of the tumor toward radio- or 
chemotherapy. Koukourakis et al. (72) found that nuclear ex-
pression of APEl/Ref-1 in head-and-neck cancer was associ-
ated with resistance to cisplatin chemoradiation therapy and 
poor outcome. Herring et al. (53) reported the existence of an 
inverse relationship between intrinsic radiosensitivity and the 
levels of APEl/Ref-1 in cervical carcinoma. However, these 
are not general features of all tumors. In fact, although it has 
been clearly demonstrated that a subcellular disregulation 
was associated with the onset of the tumorigenic process in 
ovarian cancer (79), APEl/Ref-1 expression was ubiquitous 
between different epithelial ovarian cancers and was unal-
tered during the metastatic process (33). Moreover, APEi/ 
Ref-I proved not to be a useful biornarker for platinum resis-
tance, because there was no difference in its expression 
among platinum-sensitive and platinum-refractory ovarian 
cancers. These recent outcomes highlight the fact that much 
work needs to be done it1 order to understand the real possi-
bility of using APEl/Ref-1 as a therape\1tic target. 
Probably, the right direction in which to investigate the role 
played by APEI/Ref-1 in tumorigenesis is that indicated by 
recent results on PT modifications of APEl/Ref-1 itself. In 
particular, Orii et al. (86) investigated the role played by 
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APEl/Ref- 1 in uterine leiomyomas; the most common benign 
smooth muscle tumors in the myometrium, by evaluating its 
expression at both the mRNA and protein levels. Despite the 
presence of a unique mRNA transcript, these authors were 
able to detect at least two forms of the protein by using a 
combination of three antibodies raised against different epi-
topes of the protein itself. The large form of the protein, 
prominent in leiomyoma extracts with respect to myometrial 
tissue extracts, was correlated with PCNA levels, suggesting 
an association with increased proliferation (86). These obser-
vations on PT modifications of APEl/Ref-1, coupled with 
those cited in the previous paragraph on acetylation and 
phosphorylation, confirm a new investigative direction for 
the comprehension of APEl/Ref-1 multifaceted function and 
for its therapeutic potential. 
Cellular oxidative stress is a common pathogenic eve11t in 
different disorders, therefore, it was expected thatAPEt/Ref-
1 expression and/or subcellular localization could be affected 
in those pathologies where oxidative stress is a shared fea-
ture. Other than in proliferative disorders mentioned above, 
APEl/Ref-1 disregulation has also been demonstrated for 
other pathologies, particularly degenerative disorders. Gillar-
don et al. ( 42) observed that transient global ischemia in-
duced by cardiac arrest was able to activate both APEl/Ref-1 
mRNA expression and protein nuclear accumulation in gran-
ular cells of the ischemia-resistant den late gyrus at 6 h after 
injury. In contrast, these effects where absent in CAl pyrami-
dal neurons of the postischemic hippocampus. Moreover, the 
decrease in APEI/Ref-1 protein, but not in its mRNA, was 
followed by an increase in the apoptotic rate, suggesting the 
presence of an opposite relationship existing among APEl/ 
Ref-! expression and apoptosis. The lack of correspondence 
between mRNA and protein levels emphasizes the impor-
tance of studying protein PT modifications to understand the 
functional roles and regulation of APEl/Ref-1 protein. Evi-
dence published by Gi!lardon et al. (42) suggests that, in the 
case of CA I pyramidal neurons, these discrepancies could be 
due to the presence of a posttranscriptional block during the 
translation process or to an increased degradation of the pro-
tein upon ischemia. Interestingly, it was also demonstrated 
that APEl/Ref-1 may undergo ubiquitination by Ubc9 en-
zyme ( 141 ). A similar decrease of APE l/Ref-1 protein levels 
was recently observed in motor neurons in a rabbit model of 
spinal cord ischemia by Sakurai et al. (99). It is noteworthy 
that this reduction preceded oxidative DNA damage and may 
constitute one of the factors responsible for the delay in neu-
ronal death after spinal cord ischemia. It is probably not ca-
sual that cells characterized by a high rate of metabolic activ-
ities, such as neurons, are also vulnerable when DNA repair 
or redox controlling systems are defective. In fact, these cells 
are a particular target of the noxious effects of ROS at both 
the DNA and protein levels. Another important neurological 
disorder with which APEl/Ref-1 has been associated is Alz-
heimer's disease. Hippocampi of affected patients show an in-
crease inAPEl/Ref-1 levels in senile plaques and plaque-like 
structures (109). This evidence accounts for a wider involve-
ment of the DNA repair mechanisms in Alzheimer's disease, 
as recently suggested by Davydov et al. (19). 
Recent evidence also points to a role of APEl/Ref-1 in car-
diovascular disease. Analysis of endomyocardial biopsies 
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from patients with dilated cardiomyopathy demonstrated an 
association between left ventricular wall stress and up-regula-
tion of APEl/Ref-1 expression associated with active DNA 
repair (4). Blood vessels are also subjected to disorders with 
an oxidative stress-based etiopathogenesis. In fact, ROS for-
mation is a crucial event in atherosclerosis because it causes 
oxidation of low-density lipoprotein, hyperproliferation, and, 
when damage is excessive, apoptosis. In this light, it is not 
surprising that several DNA repair systems involved in BER, 
such as APEl/Ref-1, are associated with this pathology (76). 
Finally, two other pathologies in which APEl/Ref-1 al-
teration is involved are inclusion body myositis (IBM) and 
preeclampsia. In the first case, APEl/Ref-1 localized in 
paired-helical filaments, amyloid-like fibrils, and amorphous 
material in muscle of IBM patients suggested a role played by 
APEI/Ref-1 in IBM pathogenesis (10). In the second case, an 
up-regulation of APEI/Ref-1 and TRX was associated with 
preeclampsia and intrauterine growth restriction in compli-
cated pregnancies, definitively suggesting that cellular redox 
regulation is affected in the pathophysio[ogy of this disorder 
(108). 
CONCLUDING REMARKS 
AND PERSPECTIVES 
APEI/Ref-1 is a perfect paradigm of the functional com-
plexity of a biological macromolecule. First, as a transcrip-
tional coactivator, it impacts on a wide variety of ce!Iular 
functions ranging from the control of proliferation to apopto-
sis, cytokines, and hormone signaling where ROS are mainly 
produced and function as second messengers. Second, as a 
DNA-repair enzyme, it plays a fundamental role in the BER 
pathways of DNA lesions caused by oxidants and/or alkylat-
ing agents. Therefore, asAPEl/Ref-1 is a master player of the 
above-mentioned cellular decisions, it is not surprising that 
(a) it is critical to the survival of animals (136); (b) it is ubiq-
uitously expressed in every cell type, and (c) generally, it is 
quite abundantly expressed. However, for a coordinated and 
strictly integrated functioning of APEl/Ref-1 in the proper 
biological context, it is necessary that its different functions 
must be highly regulated. It is known that APEl/Ref-1 is an 
inducible protein whose expression is controlled mainly at 
the transcriptional level by the action of APEl/Ref-1 itself, 
which functions as a suppressor of its own promoter activity 
(62), thus constituting an autoregulatory loop. Moreover, it is 
coming to light that compartmentalization of the protein in 
different subcellular districts, such as nucleus, ER, or mito-
chondria, may explain the different functional specificities. 
This is particularly reinforced by its complex and heteroge-
neous staining pattern, which is typical of each cell type, and 
by the fact that the peculiar subcellular distribution is usually 
lost during cancer progression, or a cytoplasm to nucleus 
translocation occurs upon oxidative stimuli in different cell 
types. All this evidence suggests that subcellular localization 
and trafficking of APEl/Ref-1 should be highly regulated 
processes. However, they open another problem by shifting 
the molecular question to the mechanisms responsible for the 
control of a so highly regulated process. Hopefully, convinc-
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ing answers will come from the studies on PT modifications 
occurring onAPEl/Ref-1 and responsible for the coordinated 
control of its different functions. Recent evidence suggests 
that at least three kinds of PT modifications affect APEl/Ref-
1 primary structure, i.e., phosphorylation, redox, and acetyla-
tion, and condition its function. This way of looking at the 
problem of APE! /Ref-1 functioning holds the promise of rep-
resenting the "Rosetta stone" for the comprehension of this 
unique biological molecule. 
Further improvement in unraveling the "world" of APEl/ 
Ref-1 will also come from new proteomics approaches de-
voted to the investigation ofa biological problem as a whole. 
The identification of APEl/Ref-1 "interactomes" under dif-
ferent biological conditions will lead to a deeper tmderstand-
ing of the role played by this multifaceted protein in different 
biological systems. These outcomes will be of help in devel-
oping new strategies based on different APEI/Ref-1 func-
tions as therapeutic targets for the several pathologies in 
which the protein plays a role, such as cancer, neurodegenera-
tive, and immunological disorders. The recent chemogenomic 
identification of APEl/Ref-1 as a therapeutic target for asthma 
is suggestive for a promising scenario in the near future (82). 
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